about
Targeting mast cells in gastric cancer with special reference to bone metastasesThe role of lymphangiogenesis and angiogenesis in tumor metastasisVEGFR-2 expression in human melanoma: revised assessment.Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases.The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceLymphangiogenesis and lymphatic metastasis in breast cancer.Endothelial cell Bcl-2 and lymph node metastasis in patients with oral squamous cell carcinoma.Lymphangiogenesis: a new player in cancer progression.Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic diseaseLymphatics in lung disease.Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.Role of the RNA-binding protein IMP-2 in muscle cell motility.miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C)Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinomaSunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathwaysSnail1 mediates hypoxia-induced melanoma progressionTumor lymphangiogenesis as a potential therapeutic target.The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis.Tube-like structures with co-expression of D2-40 and CD34: newly formed vasculatures?Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patientsLung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expressionSentinel node and mechanism of lymphatic metastasis.Heparanase induces VEGF C and facilitates tumor lymphangiogenesis.Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells.Leptin promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-27b in human chondrosarcoma cells.Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinomaAngiogenesis and lymphangiogenesis are downregulated in primary breast cancerThe Role of PPARs in the Endothelium: Implications for Cancer TherapyCombination of antiangiogenesis with chemotherapy for more effective cancer treatment.Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells.Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery.Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer.
P2860
Q26784456-C6E6C832-BEEE-4F01-81D9-26B10D8BB9D8Q28067309-908C676D-5998-499F-924A-291E34C3AFC4Q30423356-0DBE0506-D5AA-4F9E-8491-644890351A5AQ30438929-FF2A9CC0-CAB5-4FEA-8DBF-612880584796Q30841144-2F1FA5F7-1E66-48E0-92E1-1F53BF032FADQ33614283-5F02E3D6-DFDA-40D4-BFF7-00148A3713B6Q33759991-34B29B09-0C11-468A-90B0-1632596FAE1FQ33940058-8CA3B270-A8E3-49EE-BFAE-3E691BE019C3Q34026770-39ABF64E-B8A0-44DD-8196-01B8116AB791Q34084937-CE4345EF-1CB1-4395-9224-B494ACCE60B9Q34091198-AAB5BA79-350B-46A8-8684-C62E7CDDE915Q34160672-D0B5CD6E-534F-4E41-91A2-B76382074C2DQ34251088-A9F310F1-67E5-4983-A45E-54B03BBB7089Q34321539-0780E7E1-F526-435C-8696-8290DE331350Q34416295-6CE57CAD-6E40-4504-9FCF-3D2057AB50A6Q34673760-0ECE7177-DFEA-48CD-A55A-FCE923B7A903Q34869695-A628C154-53EC-45F4-B706-9EB81AC65257Q35019991-DDB5D5E0-57D6-43A7-B129-3AC79EBEC8ABQ35087391-2CFECD47-C5A7-4931-BE88-DC2130E13F8AQ35558123-794E5C88-9B38-4C88-BC4B-08327A83EBBDQ35597013-AEF3F15D-C541-44E1-BF96-DAE72362CFB4Q35679320-7A656D49-F037-42E7-B3AD-1FB626897551Q35838122-F4DB819E-3BB3-480F-B014-B5E210EB2B4AQ36241051-A6289279-3681-43C1-9F65-91BD695008E2Q36378151-7F7B9FBA-05F5-4D58-BB8C-E8005745730EQ36402488-F41DF6FD-7783-4DE2-BE3C-40A6D92A0508Q36645960-D1C721A8-FF44-4B26-AF09-059276A12064Q36679422-6B0B52E4-154E-4128-A771-0A21AE2B7A7CQ36953862-571402BE-FAA0-4EC8-8075-478CC26B7A14Q37028329-F829F69A-BFE2-4F88-AD59-15C0F3B58B19Q37040086-B7A7C7C9-86F1-4BF5-AB44-8D0752EF79C0Q37169670-8EDB2C88-77F4-43B5-B749-58EF910F84ADQ37330675-D202B18C-B10B-409A-863E-587FA45EA955Q37337997-BFC64ED2-F1D4-44FB-901A-4B7279C5B2E2Q37346912-47467EEC-8C57-41A1-9E09-E853FC70B0ACQ37373141-1FAB455A-6CCC-4221-AB6E-2E8E600C5CD5Q37392753-A9ACDE3E-3C57-4F85-94A2-6CD094003A6CQ37392868-4953FCCA-6D59-40C7-84F4-D31E5C3C74D0Q37465651-B38822B3-B68C-4CD4-B091-8E59E8135737Q37947968-388F6E5C-79D3-4F32-9D4C-1E24168D701C
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pathways targeting tumor lymphangiogenesis.
@ast
Pathways targeting tumor lymphangiogenesis.
@en
type
label
Pathways targeting tumor lymphangiogenesis.
@ast
Pathways targeting tumor lymphangiogenesis.
@en
prefLabel
Pathways targeting tumor lymphangiogenesis.
@ast
Pathways targeting tumor lymphangiogenesis.
@en
P1476
Pathways targeting tumor lymphangiogenesis.
@en
P2093
Christoph Wissmann
P304
P356
10.1158/1078-0432.CCR-06-1800
P407
P577
2006-12-01T00:00:00Z